Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype

An epidemic IMP-13 metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa clone, causing infections and even large outbreaks in Italian critical care settings, was detected in a young cystic fibrosis patient. In this patient, the chronic infection was sustained by distinct clonal sub-populations...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2011-08, Vol.17 (8), p.1272-1275
Hauptverfasser: Pollini, S., Fiscarelli, E., Mugnaioli, C., Di Pilato, V., Ricciotti, G., Neri, A.S., Rossolini, G.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1275
container_issue 8
container_start_page 1272
container_title Clinical microbiology and infection
container_volume 17
creator Pollini, S.
Fiscarelli, E.
Mugnaioli, C.
Di Pilato, V.
Ricciotti, G.
Neri, A.S.
Rossolini, G.M.
description An epidemic IMP-13 metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa clone, causing infections and even large outbreaks in Italian critical care settings, was detected in a young cystic fibrosis patient. In this patient, the chronic infection was sustained by distinct clonal sub-populations of the MBL-producing P. aeruginosa clone, either susceptible or resistant to carbapenems. These findings underscore the importance of infection prevention practices in cystic fibrosis settings and pose an important diagnostic and therapeutic challenge.
doi_str_mv 10.1111/j.1469-0691.2011.03466.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907171700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14629670</els_id><sourcerecordid>879102184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5396-8feeb16d90d595e6a25d03419f9764729f2b3dd4841649404098ae1e3c8ab3203</originalsourceid><addsrcrecordid>eNqNUsFu1DAQjRCIlsIvIF8QpwQ7dpz4wAFWUJAWwQEkbpZjT3a9SuxgJ7T5Hv6gH8I34XSXciz2wWPNezPj95xliOCCpPXqUBDGRY65IEWJCSkwZZwX1w-y87vEwxQT0eQ1o9_PsicxHjDGJaXscXZWElpXvKrPs19fIszGD96piBSEeWedjwpZ14GerHcpQnqJk9Wos23w0Uak1RzBoHZByiEYrYEhpQeYVN_7_PdN3is9qUFFyMfgzayt2yHdewfoyk57pNAeJgh-Bw78vNYLrRrTZUABUoNJOQ1o3IPz0zLC0-xRp_oIz07nRfbt_buvmw_59vPlx82bba4rKnjedAAt4UZgU4kKuCork3QhohM1Z3UpurKlxrCGEc4EwwyLRgEBqhvV0hLTi-zlsW4a-scMcZKDjRr6Xt2OKQWuSdr4fmRTC4JL0rCEbI5InaSLATo5BjuosEiC5eqlPMjVMrlaJlcv5a2X8jpRn5-azO0A5o7417wEeHECqKhV34Ukm43_cIxWuOY84V4fcVe2h-W_B5Cb7ac1Svy3Rz4k8X9aCDJqC8kiY0P6JNJ4e_9r_gDlDtOm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>879102184</pqid></control><display><type>article</type><title>Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Pollini, S. ; Fiscarelli, E. ; Mugnaioli, C. ; Di Pilato, V. ; Ricciotti, G. ; Neri, A.S. ; Rossolini, G.M.</creator><creatorcontrib>Pollini, S. ; Fiscarelli, E. ; Mugnaioli, C. ; Di Pilato, V. ; Ricciotti, G. ; Neri, A.S. ; Rossolini, G.M.</creatorcontrib><description>An epidemic IMP-13 metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa clone, causing infections and even large outbreaks in Italian critical care settings, was detected in a young cystic fibrosis patient. In this patient, the chronic infection was sustained by distinct clonal sub-populations of the MBL-producing P. aeruginosa clone, either susceptible or resistant to carbapenems. These findings underscore the importance of infection prevention practices in cystic fibrosis settings and pose an important diagnostic and therapeutic challenge.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2011.03466.x</identifier><identifier>PMID: 21375657</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; beta-Lactam Resistance - genetics ; beta-Lactamases - biosynthesis ; beta-Lactamases - genetics ; Biological and medical sciences ; Carbapenems ; Carbapenems - pharmacology ; Child ; Chronic Disease ; Chronic infection ; Cystic fibrosis ; Cystic Fibrosis - epidemiology ; Cystic Fibrosis - microbiology ; Disease Outbreaks ; Electrophoresis, Gel, Pulsed-Field ; epidemic clone ; Epidemics ; Errors of metabolism ; Female ; Humans ; Infectious diseases ; Medical sciences ; Metabolic diseases ; Metallo- beta -lactamase ; metallo-β-lactamase ; Microbial Sensitivity Tests ; Miscellaneous hereditary metabolic disorders ; Pharmacology. Drug treatments ; Phenotype ; Pseudomonas aeruginosa ; Pseudomonas aeruginosa - classification ; Pseudomonas aeruginosa - enzymology ; Pseudomonas aeruginosa - genetics ; Pseudomonas aeruginosa - isolation &amp; purification ; Pseudomonas Infections - epidemiology ; Pseudomonas Infections - microbiology</subject><ispartof>Clinical microbiology and infection, 2011-08, Vol.17 (8), p.1272-1275</ispartof><rights>2011 European Society of Clinical Infectious Diseases</rights><rights>2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases</rights><rights>2015 INIST-CNRS</rights><rights>2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5396-8feeb16d90d595e6a25d03419f9764729f2b3dd4841649404098ae1e3c8ab3203</citedby><cites>FETCH-LOGICAL-c5396-8feeb16d90d595e6a25d03419f9764729f2b3dd4841649404098ae1e3c8ab3203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1469-0691.2011.03466.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1469-0691.2011.03466.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24350766$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21375657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pollini, S.</creatorcontrib><creatorcontrib>Fiscarelli, E.</creatorcontrib><creatorcontrib>Mugnaioli, C.</creatorcontrib><creatorcontrib>Di Pilato, V.</creatorcontrib><creatorcontrib>Ricciotti, G.</creatorcontrib><creatorcontrib>Neri, A.S.</creatorcontrib><creatorcontrib>Rossolini, G.M.</creatorcontrib><title>Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>An epidemic IMP-13 metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa clone, causing infections and even large outbreaks in Italian critical care settings, was detected in a young cystic fibrosis patient. In this patient, the chronic infection was sustained by distinct clonal sub-populations of the MBL-producing P. aeruginosa clone, either susceptible or resistant to carbapenems. These findings underscore the importance of infection prevention practices in cystic fibrosis settings and pose an important diagnostic and therapeutic challenge.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>beta-Lactam Resistance - genetics</subject><subject>beta-Lactamases - biosynthesis</subject><subject>beta-Lactamases - genetics</subject><subject>Biological and medical sciences</subject><subject>Carbapenems</subject><subject>Carbapenems - pharmacology</subject><subject>Child</subject><subject>Chronic Disease</subject><subject>Chronic infection</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - epidemiology</subject><subject>Cystic Fibrosis - microbiology</subject><subject>Disease Outbreaks</subject><subject>Electrophoresis, Gel, Pulsed-Field</subject><subject>epidemic clone</subject><subject>Epidemics</subject><subject>Errors of metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Metallo- beta -lactamase</subject><subject>metallo-β-lactamase</subject><subject>Microbial Sensitivity Tests</subject><subject>Miscellaneous hereditary metabolic disorders</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas aeruginosa - classification</subject><subject>Pseudomonas aeruginosa - enzymology</subject><subject>Pseudomonas aeruginosa - genetics</subject><subject>Pseudomonas aeruginosa - isolation &amp; purification</subject><subject>Pseudomonas Infections - epidemiology</subject><subject>Pseudomonas Infections - microbiology</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsFu1DAQjRCIlsIvIF8QpwQ7dpz4wAFWUJAWwQEkbpZjT3a9SuxgJ7T5Hv6gH8I34XSXciz2wWPNezPj95xliOCCpPXqUBDGRY65IEWJCSkwZZwX1w-y87vEwxQT0eQ1o9_PsicxHjDGJaXscXZWElpXvKrPs19fIszGD96piBSEeWedjwpZ14GerHcpQnqJk9Wos23w0Uak1RzBoHZByiEYrYEhpQeYVN_7_PdN3is9qUFFyMfgzayt2yHdewfoyk57pNAeJgh-Bw78vNYLrRrTZUABUoNJOQ1o3IPz0zLC0-xRp_oIz07nRfbt_buvmw_59vPlx82bba4rKnjedAAt4UZgU4kKuCork3QhohM1Z3UpurKlxrCGEc4EwwyLRgEBqhvV0hLTi-zlsW4a-scMcZKDjRr6Xt2OKQWuSdr4fmRTC4JL0rCEbI5InaSLATo5BjuosEiC5eqlPMjVMrlaJlcv5a2X8jpRn5-azO0A5o7417wEeHECqKhV34Ukm43_cIxWuOY84V4fcVe2h-W_B5Cb7ac1Svy3Rz4k8X9aCDJqC8kiY0P6JNJ4e_9r_gDlDtOm</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Pollini, S.</creator><creator>Fiscarelli, E.</creator><creator>Mugnaioli, C.</creator><creator>Di Pilato, V.</creator><creator>Ricciotti, G.</creator><creator>Neri, A.S.</creator><creator>Rossolini, G.M.</creator><general>Elsevier Ltd</general><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>201108</creationdate><title>Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype</title><author>Pollini, S. ; Fiscarelli, E. ; Mugnaioli, C. ; Di Pilato, V. ; Ricciotti, G. ; Neri, A.S. ; Rossolini, G.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5396-8feeb16d90d595e6a25d03419f9764729f2b3dd4841649404098ae1e3c8ab3203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>beta-Lactam Resistance - genetics</topic><topic>beta-Lactamases - biosynthesis</topic><topic>beta-Lactamases - genetics</topic><topic>Biological and medical sciences</topic><topic>Carbapenems</topic><topic>Carbapenems - pharmacology</topic><topic>Child</topic><topic>Chronic Disease</topic><topic>Chronic infection</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - epidemiology</topic><topic>Cystic Fibrosis - microbiology</topic><topic>Disease Outbreaks</topic><topic>Electrophoresis, Gel, Pulsed-Field</topic><topic>epidemic clone</topic><topic>Epidemics</topic><topic>Errors of metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Metallo- beta -lactamase</topic><topic>metallo-β-lactamase</topic><topic>Microbial Sensitivity Tests</topic><topic>Miscellaneous hereditary metabolic disorders</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas aeruginosa - classification</topic><topic>Pseudomonas aeruginosa - enzymology</topic><topic>Pseudomonas aeruginosa - genetics</topic><topic>Pseudomonas aeruginosa - isolation &amp; purification</topic><topic>Pseudomonas Infections - epidemiology</topic><topic>Pseudomonas Infections - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pollini, S.</creatorcontrib><creatorcontrib>Fiscarelli, E.</creatorcontrib><creatorcontrib>Mugnaioli, C.</creatorcontrib><creatorcontrib>Di Pilato, V.</creatorcontrib><creatorcontrib>Ricciotti, G.</creatorcontrib><creatorcontrib>Neri, A.S.</creatorcontrib><creatorcontrib>Rossolini, G.M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pollini, S.</au><au>Fiscarelli, E.</au><au>Mugnaioli, C.</au><au>Di Pilato, V.</au><au>Ricciotti, G.</au><au>Neri, A.S.</au><au>Rossolini, G.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2011-08</date><risdate>2011</risdate><volume>17</volume><issue>8</issue><spage>1272</spage><epage>1275</epage><pages>1272-1275</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>An epidemic IMP-13 metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa clone, causing infections and even large outbreaks in Italian critical care settings, was detected in a young cystic fibrosis patient. In this patient, the chronic infection was sustained by distinct clonal sub-populations of the MBL-producing P. aeruginosa clone, either susceptible or resistant to carbapenems. These findings underscore the importance of infection prevention practices in cystic fibrosis settings and pose an important diagnostic and therapeutic challenge.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>21375657</pmid><doi>10.1111/j.1469-0691.2011.03466.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2011-08, Vol.17 (8), p.1272-1275
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_907171700
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
beta-Lactam Resistance - genetics
beta-Lactamases - biosynthesis
beta-Lactamases - genetics
Biological and medical sciences
Carbapenems
Carbapenems - pharmacology
Child
Chronic Disease
Chronic infection
Cystic fibrosis
Cystic Fibrosis - epidemiology
Cystic Fibrosis - microbiology
Disease Outbreaks
Electrophoresis, Gel, Pulsed-Field
epidemic clone
Epidemics
Errors of metabolism
Female
Humans
Infectious diseases
Medical sciences
Metabolic diseases
Metallo- beta -lactamase
metallo-β-lactamase
Microbial Sensitivity Tests
Miscellaneous hereditary metabolic disorders
Pharmacology. Drug treatments
Phenotype
Pseudomonas aeruginosa
Pseudomonas aeruginosa - classification
Pseudomonas aeruginosa - enzymology
Pseudomonas aeruginosa - genetics
Pseudomonas aeruginosa - isolation & purification
Pseudomonas Infections - epidemiology
Pseudomonas Infections - microbiology
title Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T23%3A52%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pseudomonas%20aeruginosa%20infection%20in%20cystic%20fibrosis%20caused%20by%20an%20epidemic%20metallo-%CE%B2-lactamase-producing%20clone%20with%20a%20heterogeneous%20carbapenem%20resistance%20phenotype&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Pollini,%20S.&rft.date=2011-08&rft.volume=17&rft.issue=8&rft.spage=1272&rft.epage=1275&rft.pages=1272-1275&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2011.03466.x&rft_dat=%3Cproquest_cross%3E879102184%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=879102184&rft_id=info:pmid/21375657&rft_els_id=S1198743X14629670&rfr_iscdi=true